SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NKTR Drug delivery Company
NKTR 58.00+3.6%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (379)3/5/2013 10:11:49 AM
From: ghmm  Read Replies (2) of 507
 
Looks like we got that break above 9.50 :-).

I didn't see any news and heard the Cowen call this morning. Nothing I thought new in it though continue to be generally bullish. I think since the setback with the other opioid drug and the Street articles people have discounted NKTR-118. If they file in Q3 and it gets approved the stock should be much higher on this alone. On the quarterly call they estimated an interim for 102 in Breast could happen around year end (also around when enrollment would be completed). Don't recall if they've disclosed the alpha think its very small so probably a very high bar to hit then.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News